Source link : https://newshealth.biz/health-news/fda-wants-drug-pulled-from-market-citing-liver-risk-company-says-no/
(MedPage Today) — The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, but the company said it has no plans to pull the drug from the market… Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/119741 Author : Publish date : 2026-02-04 21:29:00 Copyright for syndicated content belongs to the linked […]
The post FDA Wants Drug Pulled From Market, Citing Liver Risk. Company Says No first appeared on News Health.
—-
Author : News Health
Publish date : 2026-02-04 21:29:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8